Latest news with #NurseMagic
Associated Press
16-05-2025
- Business
- Associated Press
Amesite Announces Quarterly Revenue Increase of 2.4x in 10-Q Filing
DETROIT, May 16, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced its flagship app NurseMagicTM generated 2.4x revenue from Q2/2025 to Q3/2025, even as the company continued to cut operating expenses. Sarah Berman, Principal Financial and Accounting Officer, said, 'Our revenues are presently evenly distributed between B2B and B2C sales. Following the launch of NurseMagicTM in Q4/2024, revenues were stable from Q1/2025 to Q2/2025. However, in Q3/2025, we had a significant increase of 2.4x in revenue, following execution of targeted sales and marketing motions and rollouts of product enhancements. We also further reduced expenses while scaling sales this past quarter, retaining our strong focus on achieving further operational efficiencies and managing margins to drive to profitability.' Brandon Owens, VP of Sales, said, 'We delivered Teams Plus+ to our B2B customers in direct response to their need for greater intensity of usage, and expect accelerated business demands for more services, given the feedback. Our product testimonials are our best sales assets, and we are closing sales and onboarding teams within days or weeks, because of the efficiency of our payments and onboarding workflows.' Madison Bush, Director of Corporate Operations, said, 'We saw user growth of 1340% over Q3, following the launch of paid subscriptions in Q2. We have expanded our mobile marketing and are communicating with our users at every step of their journey to attract and retain them. We are thrilled to see that nurses who are searching for AI-tools are finding and using NurseMagicTM because it delivers incredible value. ' Dr. Ann Marie Sastry, CEO and Founder, said, 'We are confident that we can continue to deliver NurseMagicTM at an affordable price point to both B2C and B2B customers, while maintaining healthy margins – and look forward to more growth in Q4. Our outstanding customer feedback validates a strong product-market fit. With our nimble development process, we feel that we are in very good position to grow revenue efficiently, while delivering tiered services that enable us to expand into new segments opportunistically.' Amesite is focused on delivering value in large, growing segments, including the 16,700 Skilled Nursing and Home Health Care Facilities in the U.S., employing 1.38 million workers, and 8,514 hospice organizations employing 407,692 workers. With a total of 5.2 million RNs and 630,000 LPNs in the U.S., and demand rising across Senior Living, Skilled Nursing, and Hospice, Amesite is positioned with solutions that meet real needs. Recent rollouts include delivering to the growing hospice segment, meeting HIPAA requirements for all users, and offering a new, higher-priced tier for B2B users. About Amesite Inc. Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments. Its flagship product, NurseMagicTM, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagicTM is used by over 100 professions to improve care, enhanced operational efficiency and improved financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. Forward-Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as 'may,' 'will,' 'should,' 'would,' 'expect,' 'plan,' 'believe,' 'intend,' 'look forward,' and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations [email protected]
Yahoo
02-03-2025
- Business
- Yahoo
Amesite Inc. (AMST) Accelerates NurseMagic Sales with 95% Faster Enterprise Onboarding
We recently compiled a list of the . In this article, we are going to take a look at where Amesite Inc. (NASDAQ:AMST) stands against the other AI stocks. Just as the AI industry was catching up with the launch of the DeepSeek AI R1 model in January, sources divulged that the Hangzhou-based company is planning to release the R2 model as early as possible. The company was previously aiming to launch the R2 model in May. DeepSeek expects the R2 model to exhibit better coding and reasoning capabilities in multiple languages. The R1 model, which was built cost-effectively using relatively less powerful GPUs, triggered a $1 trillion sell-off in US and European markets. The speculation around the R2 model could potentially drive further volatility in America's AI landscape as investors question the narrative that US-based AI companies require hundreds of billions of dollars to develop AI systems. "The launch of DeepSeek's R2 model could be a pivotal moment in the AI industry. DeepSeek's success at creating cost-effective AI models would likely spur companies worldwide to accelerate their own efforts ... breaking the stranglehold of the few dominant players in the field." We selected AI stocks by reviewing news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey's database of over 1000 hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). A computer screen showcasing Artificial Intelligence and Machine Learning algorithms at work. Amesite Inc. (NASDAQ:AMST) uses proprietary AI in its NurseMagic tool to streamline documentation workflow, improve patient communication, and save time for nurses and caregivers. Their HIPAA-compliant B2C and B2B solutions are helping to enhance operational efficiency, uplift care quality, and boost overall financial performance in the home care, hospice, and healthcare segments. On February 25th, Amesite Inc. (NASDAQ:AMST) announced the success of its automated sales flow for its enterprise solution, NurseMagic for Teams. The company claims that the new purchase flow has reduced the time to close an enterprise sale by 95%, as enterprise clients can complete their NurseMagic subscription in minutes. The result is higher sales conversion and technology adoption alongside lower audit risks and negative reviews for clients, as they now have the capability to onboard teams immediately on the platform. 'Speed matters in enterprise sales, especially in healthcare, where time saved translates directly to better patient care. With our successful, automated sales flow, healthcare organizations are onboarding employees onto the NurseMagic™ app in record time, ensuring their teams can start experiencing efficiency gains immediately.' Overall AMST ranks 8th on our list of AI stocks that investors likely missed. While we acknowledge the potential of AMST as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AMST but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
